ALIBREX Trademark Information

Trademark by Cadex Genomics, Corp.

Medical diagnostic assays for testing of bodily fluids, namely, assays used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy; Medical diagnostic test media in the form of reagents used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy; medical diagnostic kits comprised of medical diagnostic reagen...

Medical and scientific research in the field of medical diagnostic assays and clinical testing services for the purpose of testing of bodily fluids used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy

Medical testing for diagnostic or treatment purposes, namely, for the purpose of testing of bodily fluids used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy

Classification Information

Use in Commerce Trademark - Applicant has provided proof of use of this mark in commerce to USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
Class (042)
Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
Class (044)
Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
General Information
Word mark: ALIBREX
Status/Status Date:
REGISTERED
9/22/2020
Serial Number: 88299485
Filing Date: 2/13/2019
Registration Number: 6159041
Registration Date: 9/22/2020
Goods and Services: Medical diagnostic assays for testing of bodily fluids, namely, assays used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy; Medical diagnostic test media in the form of reagents used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy; medical diagnostic kits comprised of medical diagnostic reagents and assays used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy
Mark Description: NOT AVAILABLE
Type Of Mark: Service Mark
Published For Opposition Date: 12/10/2019
Last Applicant/Owner:
Cadex Genomics, Corp.
Redwood City, CA 94063
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
CROWELL & MORING LLP
590 MADISON AVENUE, 20th Floor
NEW YORK, NY 10022
Current Status:
REGISTERED
9/22/2020
Correspondent Search:
JAMES K. STRONSKI is a correspondent of ALIBREX trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on